Contacts:Optimer Pharmaceuticals, Inc. David Walsey, Vice President, Investor Relations and Corporate Communications858-964-3418Canale Communications, Inc. Jason I. Spark, Senior Vice President619-849-6005 SOURCE Optimer Pharmaceuticals, Inc.
Cubist Pharmaceuticals on Tuesday committed up to $1.6 billion to acquire two makers of next-generation antibiotics in a bid to expand aggressively its acute care product portfolio.
Stock futures are little changed Wednesday despite upbeat reports on GDP and jobs ahead of the Fed announcement.
Cubist announces two acquisitions in one day.